These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12392842)

  • 1. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
    Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
    J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
    Rademaker MT; Charles CJ; Ellmers LJ; Lewis LK; Nicholls MG; Richards AM
    Hypertension; 2011 Jun; 57(6):1136-44. PubMed ID: 21536988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
    Eur Heart J; 2005 Oct; 26(19):2055-62. PubMed ID: 15961410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart Failure.
    Scott NJA; Rademaker MT; Charles CJ; Espiner EA; Richards AM
    J Am Coll Cardiol; 2019 Aug; 74(7):889-901. PubMed ID: 31416533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.
    Rademaker MT; Yandle TG; Ellmers LJ; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2012 Sep; 5(5):645-52. PubMed ID: 22798523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Eur Heart J; 2006 Sep; 27(17):2088-98. PubMed ID: 16825287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure.
    Rademaker MT; Charles CJ; Richards AM
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1536-44. PubMed ID: 17526650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of urocortin 1 infusion in humans with stable congestive cardiac failure.
    Davis ME; Pemberton CJ; Yandle TG; Lainchbury JG; Rademaker MT; Nicholls MG; Frampton CM; Richards AM
    Clin Sci (Lond); 2005 Oct; 109(4):381-8. PubMed ID: 15882144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2013 Jul; 6(4):825-32. PubMed ID: 23753530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
    Eur Heart J; 2005 Oct; 26(19):2046-54. PubMed ID: 15821006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term adrenomedullin administration in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM
    Hypertension; 2002 Nov; 40(5):667-72. PubMed ID: 12411460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
    Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards AM
    J Am Coll Cardiol; 2007 Jan; 49(4):461-71. PubMed ID: 17258092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Lewis LK; Yandle TG; Cooper GJ; Coy DH; Richards AM; Nicholls MG
    Circulation; 1997 Sep; 96(6):1983-90. PubMed ID: 9323090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2008 Jul; 1(2):134-42. PubMed ID: 19808282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
    Troughton RW; Rademaker MT; Powell JD; Yandle TG; Espiner EA; Frampton CM; Nicholls MG; Richards AM
    Hypertension; 2000 Oct; 36(4):523-30. PubMed ID: 11040230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic, hormonal, and renal actions of adrenomedullin-2 in normal conscious sheep.
    Charles CJ; Rademaker MT; Richards AM
    Endocrinology; 2006 Apr; 147(4):1871-7. PubMed ID: 16410298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2012 May; 122(9):429-37. PubMed ID: 22087608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.